G. Riemekasten

Publication List Details

Period

2001 - 2005

Number

9

Co-Authors

A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus.

Riemekasten, G, Marell, J, Trebeljahr, G, Klein, R, Hausdorf, G, Häupl, T, ...

The SmD1 protein is a specific target for the autoantibody response in SLE. To further analyze this reactivity epitope, mapping was performed with cellulose-bound 13-mer peptides overlapping 10 amino...

A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus.

Riemekasten, G, Marell, J, Trebeljahr, G, Klein, R, Hausdorf, G, Häupl, T, ...

The SmD1 protein is a specific target for the autoantibody response in SLE. To further analyze this reactivity epitope, mapping was performed with cellulose-bound 13-mer peptides overlapping 10 amino...

T cell reactivity against the SmD183–119 C terminal peptide in patients with systemic lupus erythematosus

Riemekasten, G, Weiss, C, Schneider, S, Thiel, A, Bruns, A, Schumann, F, ...

Background: The SmD183–119 peptide is a major target of the B cell response in patients with systemic lupus erythematosus (SLE).

The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement

Hunzelmann, N., Genth, E., Krieg, T., Lehmacher, W., Melchers, I., Meurer, M., ...

Objective. Systemic sclerosis (SSc) is a rare, heterogeneous disease, which affects different organs and therefore requires interdisciplinary diagnostic and therapeutic management. To improve the...